Rheumatoid arthritis is more than joint pain; it is a systemic autoimmune disease in which the body’s immune system mistakenly attacks joint linings. Early recognition and modern treatment have transformed prognosis over the past two decades.
How RA Differs From Other Arthritis
Unlike osteoarthritis, which arises from wear and tear, RA is driven by immune dysregulation. The synovial lining of joints becomes inflamed, releasing enzymes that erode cartilage and bone. The disease typically affects multiple joints symmetrically.
Common Early Signs
Morning stiffness lasting more than an hour, joint swelling in the hands and feet, fatigue, and low-grade fever are typical early features. Small joints are usually affected first, particularly the knuckles and wrists.
Beyond the Joints
RA can affect organs throughout the body. Patients may develop dry eyes, lung nodules or interstitial lung disease, increased cardiovascular risk, and rheumatoid nodules under the skin. Inflammation is systemic, even when symptoms feel local.
Diagnostic Tools
Rheumatoid factor and anti-CCP antibodies appear in blood tests in most patients. Imaging may show characteristic joint erosions. Inflammation markers like ESR and CRP help track disease activity over time.
Treatment Has Transformed
Disease-modifying antirheumatic drugs (DMARDs), particularly methotrexate, can substantially slow joint damage. Biologic medications targeting specific immune pathways have given patients with severe disease far better outcomes. Treatment aims for remission rather than just symptom control.
Living Well With RA
Regular exercise, joint protection techniques, smoking cessation, and stress management all support medical treatment. Most patients work with a rheumatologist, primary care provider, and often physical and occupational therapists. For comprehensive RA information, the Arthritis Foundation offers detailed patient resources.